Globally, one of the primary factors leading to death is cardiovascular disorders, specifically
coronary artery disease, which leads to myocardial infarction (MI). This article investigates …

Myocardial infarction is the most common cause of congestive heart failure. Novel strategies
such as directly reprogramming cardiac fibroblasts into cardiomyocytes are an exciting area …

Myocardial infarction is the leading cause of death in the world's population. The sudden
and progressive loss of cardiomyocyte contractile cells due to infarction is disproportionate …

Platelet-rich plasma (PRP) is a widely accepted treatment approach and has heightened the
quality of care among physicians. PRP has been used over the last decade to boost clinical …

We read with great interest the article by Kislitsina et al [1] titled “Unlocking the secrets to
regenerating cardiac tissue: an update”. The authors present an article that is focused on …

OBJECTIVE: Cell therapy is an exciting area of investigation for repair of injured myocardial
tissue. Platelet-rich plasma (PRP) is an autologous fractionation of whole blood containing …

Objective Platelet activation and subsequent release of granules containing a variety of
growth factors, at the site of injury, is crucial for the wound healing process. We postulated …

Stem and progenitor cells have evolved as the central cell type in regenerative medicine.
This focussed approach may, however, sometimes narrow the point of view. Recently …

Our understanding of platelet function has traditionally focused on their roles in
physiological hemostasis and pathological thrombosis, with the latter being causative of …

Background Restoration of dysfunctional tissue using autologous methods such as platelet-
rich plasma (PRP) has become an attractive field of research as of late. Experimental …